Refractive technology has come a long way, but its survival and success are not merely attributable to improved outcomes. They are also due to adjusted expectations and how you communicate with your patients.
The literature demonstrates that nasal corticosteroids benefit patients with ocular allergies. But, clinical experience doesn’t always agree. What’s best for your patients?